title: Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors.
abstract: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. Within the molecular scope of NCSLC, a complex landscape of dysregulated cellular signaling has emerged, defined largely by mutations in select mediators of signal transduction, including the epidermal growth factor receptor (EGFR) and anaplastic lymphoma (ALK) kinases. Consequently, these mutant kinases become constitutively activated and targets for chemotherapeutic intervention. Encouragingly, small molecule inhibitors of these pathways have shown promise in clinical trials or are approved for clinical use. However, many protein kinases are dysregulated in NSCLC without genetic mutations. To quantify differences in tumor cell signaling that are transparent to genomic methods, we established a super-SILAC internal standard derived from NSCLC cell lines grown in vitro and labeled with heavy lysine and arginine, and deployed them in a phosphoproteomic workflow. We identified 9019 and 8753 phosphorylation sites in two separate tumors. Relative quantification of phosphopeptide abundance between tumor samples allowed for the determination of specific hubs and pathways differing between each tumor. Sites downstream of Ras showed decreased inhibitory phosphorylation (Raf/Mek) and increased activating phosphorylation (Erk1/2) in one tumor versus another. In this way, we were able to quantitatively access oncogenic kinase signaling in primary human tumors.
  
  
  CONCLUSIONS
  Through the use of quantitative proteomics, we demonstrated the feasibility and coverage that large scale mass spectrometry can leverage for understanding kinase networks in cancer. By incorporating Super-SILAC based quantitation into a typical pathology workflow, we were able to access and compare tumors from multiple patients in this analysis with high accuracy and dynamic range. We analyzed tumors from patients diagnosed with non-small cell lung cancer and were able to detect comprehensive phosphorylation networks relaying through known hubs of oncogenesis in lung cancer. We hereby show that it is possible to track changes to phosphorylation networks across multiple tumors, opening up the possibility that drug susceptibility and patient-specific stratification can be implemented downstream of classical pathology.
authors.affiliation: Department of Genetics, Geisel School of Medicine, Lebanon, NH 03756, United States.
authors.forename: Devin K
authors.initials: DK
authors.lastname: Schweppe
authors.forename: James R
authors.initials: JR
authors.lastname: Rigas
authors.forename: Scott A
authors.initials: SA
authors.lastname: Gerber
mesh_terms: D020816:Amino Acid Motifs; D001120:Arginine / Q000737:chemistry; D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism*; D045744:Cell Line, Tumor; D066246:ErbB Receptors / Q000378:metabolism; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007553:Isotope Labeling; D008175:Lung Neoplasms / Q000378:metabolism*; D008239:Lysine / Q000737:chemistry; D009154:Mutation; D010750:Phosphoproteins / Q000378:metabolism*; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors / Q000737:chemistry; D020543:Proteome / Q000378:metabolism*; D040901:Proteomics; D015398:Signal Transduction
chemical_list: D010750:Phosphoproteins; D047428:Protein Kinase Inhibitors; D020543:Proteome; D001120:Arginine; D066246:ErbB Receptors; D048049:Extracellular Signal-Regulated MAP Kinases; D008239:Lysine
keywords: Lung cancer; Phosphoproteomics; Quantitative proteomics; SILAC
references.citation: Anal Chem. 2010 Aug 15;82(16):6821-9
references.pmid: 20684545
references.citation: Mol Cell Proteomics. 2008 Sep;7(9):1587-97
references.pmid: 18487603
references.citation: Nat Protoc. 2008;3(10):1630-8
references.pmid: 18833199
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9773-8
references.pmid: 16785428
references.citation: Science. 2004 Aug 20;305(5687):1163-7
references.pmid: 15284455
references.citation: Mol Cell Proteomics. 2012 Jul;11(7):M112.016998
references.pmid: 22499770
references.citation: Nature. 2003 Feb 27;421(6926):961-6
references.pmid: 12607005
references.citation: Nucleic Acids Res. 2012 Jan;40(Database issue):D71-5
references.pmid: 22102590
references.citation: Nat Biotechnol. 1999 Oct;17(10):994-9
references.pmid: 10504701
references.citation: Mol Cell Proteomics. 2002 May;1(5):376-86
references.pmid: 12118079
references.citation: Mol Cell Proteomics. 2013 Jan;12(1):158-71
references.pmid: 23090970
references.citation: Cell Cycle. 2010 May;9(9):1781-91
references.pmid: 20436278
references.citation: Biochim Biophys Acta. 2007 Aug;1773(8):1213-26
references.pmid: 17112607
references.citation: Mol Cell Proteomics. 2012 May;11(5):77-89
references.pmid: 22442255
references.citation: CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36
references.pmid: 21685461
references.citation: Anal Chem. 2011 Oct 15;83(20):7635-44
references.pmid: 21899308
references.citation: Nat Biotechnol. 2005 Nov;23(11):1391-8
references.pmid: 16273072
references.citation: Nat Rev Cancer. 2006 Apr;6(4):321-30
references.pmid: 16557283
references.citation: Nat Methods. 2007 Mar;4(3):207-14
references.pmid: 17327847
references.citation: Nat Protoc. 2011 Feb;6(2):175-86
references.pmid: 21293459
references.citation: Nat Methods. 2011 Jul 10;8(8):655-8
references.pmid: 21743459
references.citation: Mol Cancer Ther. 2007 Jun;6(6):1765-73
references.pmid: 17541036
references.citation: Bioinformatics. 2007 Nov 1;23(21):2947-8
references.pmid: 17846036
references.citation: Clin Cancer Res. 2004 Nov 15;10(22):7547-54
references.pmid: 15569985
references.citation: Rapid Commun Mass Spectrom. 2007;21(23):3919-26
references.pmid: 17979108
references.citation: J Biol Chem. 2006 Jan 27;281(4):2347-57
references.pmid: 16293626
references.citation: Sci Signal. 2011 Jun 28;4(179):rs5
references.pmid: 21712546
references.citation: J Natl Cancer Inst. 1997 Nov 5;89(21):1609-15
references.pmid: 9362159
references.citation: Nat Biotechnol. 2005 May;23(5):617-21
references.pmid: 15834404
references.citation: Nat Protoc. 2011 Feb;6(2):147-57
references.pmid: 21293456
references.citation: Biochim Biophys Acta. 2007 Aug;1773(8):1263-84
references.pmid: 17126425
references.citation: J Am Soc Mass Spectrom. 1994 Nov;5(11):976-89
references.pmid: 24226387
references.citation: Nat Methods. 2010 May;7(5):383-5
references.pmid: 20364148
references.citation: J Proteome Res. 2012 Nov 2;11(11):5311-22
references.pmid: 22985185
references.citation: Methods. 2003 Feb;29(2):124-30
references.pmid: 12606218
references.citation: J Proteome Res. 2010 Feb 5;9(2):1138-43
references.pmid: 19938873
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D261-7
references.pmid: 21062810
references.citation: Oncogene. 2007 May 14;26(22):3291-310
references.pmid: 17496923
references.citation: Proteomics Clin Appl. 2013 Apr;7(3-4):225-33
references.pmid: 23090905
references.citation: Proteomics. 2004 Jun;4(6):1551-61
references.pmid: 15174125
references.citation: Expert Rev Proteomics. 2011 Feb;8(1):81-94
references.pmid: 21329429
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6940-5
references.pmid: 12771378
references.citation: Nat Commun. 2011 Jul 19;2:395
references.pmid: 21772266
references.citation: Nat Biotechnol. 2001 Oct;19(10):946-51
references.pmid: 11581660
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D945-50
references.pmid: 20952405
references.citation: Cancer Res. 1992 Apr 15;52(8):2340-3
references.pmid: 1559236
references.citation: Mol Cell Proteomics. 2004 Dec;3(12):1154-69
references.pmid: 15385600
references.citation: Nat Biotechnol. 2006 Oct;24(10):1285-92
references.pmid: 16964243
references.citation: Anal Chem. 2004 Jul 15;76(14):4193-201
references.pmid: 15253663
references.citation: J Proteome Res. 2010 May 7;9(5):2734-42
references.pmid: 20222723
references.citation: Oncogene. 1997 Feb 6;14(5):543-9
references.pmid: 9053852
references.citation: N Engl J Med. 2008 Sep 25;359(13):1367-80
references.pmid: 18815398
references.citation: FEBS J. 2005 Jul;272(13):3231-40
references.pmid: 15978030
references.citation: Adv Protein Chem Struct Biol. 2010;80:1-44
references.pmid: 21109216